ArticleNature communications2024

Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.

Shixia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.